Search filters

Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Repeatability  Reproducibility  and Efficacy Testing of Automated Hemodynamic Output by Transthoracic Echocardiography
18 years - 99 years
All genders
Observational
This study will involve scanning of a patient's chest wall with an approved ultrasound device (Lumify) to obtain images prior to a patient undergoing cardiac surgery. The investigational device involved in this study will be the software that automatically outputs heart data from those chest wall images (Automated Hemodynamics Application).
 Noninvasive Quantification of Renal Oxygen Utilization in Early Kidney Disease
40 years - 59 years
Accepts healthy volunteer
All genders
PURPOSE/DESCRIPTION: The purpose of this study is to measure how much oxygen is used by the kidneys. The kidneys play an important role in removing waste products from the body. In people with chronic kidney disease and diabetes, the kidneys do not function normally and have changes in oxygen consumption. …
 COPSII: ROLE OF TELEMEDICINE STRATEGIES IN LAW ENFORCEMENT OFFICERS WITH OBSTRUCTIVE SLEEP APNEA
18 years - 85 years
All genders
Observational
This trial is looking for members of the Philadelphia police force who may have a medical condition called obstructive sleep apnea (OSA). If you have sleep apnea, your throat may close partly or completely during sleep, which causes oxygen levels in your blood to fall briefly. This can cause symptoms …
99 years or below
All genders
PROOF-HD is a placebo-controlled (double blind) multicenter Phase 3 trial of Pridopidine in Huntington Disease patients. Recruitment: 480 participants at 60 sites, a target of 8 participants per site. Procedures include administration of study drug or placebo in tablet form twice daily for a period of 67-80 weeks with option …
99 years or below
All genders
Phase 3
The primary objective is to compare the PFS of patients randomized to MIRV vs. IC Chemo. Secondary objectives include: To compare the ORR of patients randomized to MIRV vs. IC Chemo, to compare OS of patients randomized to MIRV vs. IC Chemo, and to compare the primary patient-reported outcome (PRO) …
18 years - 99 years
All genders
Phase 3
Pleae refer to Section 3 (Objectives and Endpoints) of the full protocol Please refer to Section 3.1 (Primary Endpoint) of the full protocol Please refer to Section 3.2 (Secondary Endpoints) of the full protocol
 MT-3921- Phase 2  Study to Assess the Efficacy and Safety of MT-3921 in Subjects with Acute Traumatic Cervical Spinal Cord Injury
18 years - 70 years
All genders
Phase 2
MT-3921 is an investigational monoclonal antibody therapy for patients with severe (AIS grade A-C) traumatic cervical spinal cord injury (SCIs). This study aims to compare the efficacy of MT-3921 to a placebo with regard to improving patients sensory and motor function and overall quality of life. Additionally this study aims …
 PPS Study- Screening and Classification of Pentosan-Associated Maculopathy in Patients with Interstitial Cystitis
18 years - 99 years
All genders
The primary objective of this study is to determine the prevalence of retinal changes in patients using pentosan polysulfate sodium (PPS) for treatment of interstitial cystitis and further characterize this condition using multimodal imaging. Additionally, this study aims to identify additional clinical findings associated with PPS maculopathy and to gain …
 Sample Collection for Prospera Enhancement
18 years - 99 years
All genders
Interventional
The research study is being conducted to learn how well a test called Prospera can detect rejection in a transplanted kidney after a biopsy. If results of the biopsy do not indicate rejection, the study team will follow your condition by reviewing your clinical visits for one year, at which …
 Implantation of the HeartMate 3 in Subjects with Heart Failure
18 years - 99 years
All genders
This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3.
421 - 430 of 1243